tiprankstipranks

Seth Rudnick Insider Profile

4 Followers
Seth Rudnick, Director at Aralez Pharmaceuticals, holds 9.65K shares in G1 Therapeutics (Ticker: GTHX), holds 64.39K shares in Aralez Pharmaceuticals (Ticker: ARLZQ), holds ― shares in Liquidia Technologies (Ticker: LQDA).
tipranks
Seth Rudnick

Seth Rudnick
Aralez Pharmaceuticals (ARLZQ)
Director

Ranked #79,318 out of 97,825 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-43.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$43K
100.00%
0.00%
0.00%
A breakdown of Seth Rudnick's holdings

Insider Roles

G1 Therapeutics
(GTHX)
Director
Liquidia Technologies
(LQDA)
Director
Epirus Biopharma
(EPRSQ)
Director
Roles that Seth Rudnick holds in companies

Most Profitable Insider Trade

Stock:
Aralez Pharmaceuticals
(ARLZQ)
Rating:Informative Buy
Date:Mar 17, 2017 - Mar 17, 2018
Return:-18.60%
The most profitable trade made by Seth Rudnick

Seth Rudnick's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARLZQ
Aralez Pharmaceuticals
May 12, 2017
Uninformative Buy
$128.78
G1 Therapeutics
Jun 30, 2021
Director
Uninformative Sell
223.40K
$43.16K
Liquidia Technologies
Director
Epirus Biopharma
Director
$0.00
List of latest transactions for each holding click on a transaction to see Seth Rudnick's performance on stock

Seth Rudnick insider profile FAQ

What is the percentage of profitable transactions made by Seth Rudnick?
The percentage of profitable transactions made by Seth Rudnick is 0%.
    What is the average return per transaction made by Seth Rudnick?
    The average return per transaction made by Seth Rudnick is -43.90%.
      What stocks does Seth Rudnick hold?
      Seth Rudnick holds: ARLZQ, GTHX, LQDA, EPRSQ stocks.
        What was Seth Rudnick’s latest transaction?
        Seth Rudnick latest transaction was an Uninformative Sell of $223.40K.
          What was Seth Rudnick's most profitable transaction?
          Seth Rudnick’s most profitable transaction was an Informative Buy of ARLZQ stock on March 17, 2017. The return on the trade was -18.60%.
            What is Seth Rudnick's role in Aralez Pharmaceuticals?
            Seth Rudnick's role in Aralez Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.